At a glance
ClinicalIndex Comparison RecordN/ACompleted· 122 enrolled
Drug / intervention
Vivatmo pro FeNO Testother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Study of the Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients Responding to Inhaled Corticosteroid (ICS) Treatment
In Brief
A clinical study evaluating Vivatmo pro FeNO Test for Asthma and Asthma in Children. Completed, enrolled 122 participants across 6 sites.
Detailed Summary
This is a multi-center study to evaluate fractional exhaled nitric oxide (FeNO) measured with the Vivatmo pro in adult and pediatric subjects.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAsthma, Asthma in Children
CountriesUnited States
CollaboratorsGlobal BioClinical
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedJun 2020
Enrollment StartSep 2020
Primary CompletionDec 2020
Study CompletionApr 2021
TodayJul 2026
First PostedJun 29, 2020
Enrollment StartSep 8, 2020
Primary CompletionDec 18, 2020
Study CompletionApr 13, 2021
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 6.0 years ago
Interventions
Vivatmo pro FeNO Testother
Breath gas analysis